These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2440986)

  • 1. Study of the distribution of antibody-dependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies.
    Morens DM; Larsen LK; Halstead SB
    J Med Virol; 1987 Jun; 22(2):163-7. PubMed ID: 2440986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease severity-related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies.
    Morens DM; Halstead SB
    J Med Virol; 1987 Jun; 22(2):169-74. PubMed ID: 2440987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses.
    Morens DM; Venkateshan CN; Halstead SB
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():91-8. PubMed ID: 2433388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.
    Halstead SB; Venkateshan CN; Gentry MK; Larsen LK
    J Immunol; 1984 Mar; 132(3):1529-32. PubMed ID: 6607288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.
    Henchal EA; McCown JM; Burke DS; Seguin MC; Brandt WE
    Am J Trop Med Hyg; 1985 Jan; 34(1):162-9. PubMed ID: 2578750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of antibody-dependent enhancement of dengue virus type 2 infection.
    Morens DM; Halstead SB; Marchette NJ
    Microb Pathog; 1987 Oct; 3(4):231-7. PubMed ID: 3504546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
    Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.
    Henchal EA; Gentry MK; McCown JM; Brandt WE
    Am J Trop Med Hyg; 1982 Jul; 31(4):830-6. PubMed ID: 6285749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.
    Lai CJ; Goncalvez AP; Men R; Wernly C; Donau O; Engle RE; Purcell RH
    J Virol; 2007 Dec; 81(23):12766-74. PubMed ID: 17881450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies.
    Jianmin Z; Linn ML; Bulich R; Gentry MK; Aaskov JG
    Arch Virol; 1995; 140(5):899-913. PubMed ID: 7541621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies.
    Serafin IL; Aaskov JG
    Arch Virol; 2001 Dec; 146(12):2469-79. PubMed ID: 11811694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection.
    Kaufman BM; Summers PL; Dubois DR; Cohen WH; Gentry MK; Timchak RL; Burke DS; Eckels KH
    Am J Trop Med Hyg; 1989 Nov; 41(5):576-80. PubMed ID: 2817214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.
    Smith SA; Nivarthi UK; de Alwis R; Kose N; Sapparapu G; Bombardi R; Kahle KM; Pfaff JM; Lieberman S; Doranz BJ; de Silva AM; Crowe JE
    J Virol; 2016 Jan; 90(2):780-9. PubMed ID: 26512092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisite monoclonal immunoassay for dengue viruses: detection of viraemic human sera and interference by heterologous antibody.
    Monath TP; Wands JR; Hill LJ; Gentry MK; Gubler DJ
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():639-50. PubMed ID: 2420923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an antigenic and genetic variant of dengue-4 virus from the Caribbean.
    Henchal EA; Repik PM; McCown JM; Brandt WE
    Am J Trop Med Hyg; 1986 Mar; 35(2):393-400. PubMed ID: 3513650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Dengue Virus Serotype-Specific NS1 Capture Assays for the Rapid and Highly Sensitive Identification of the Infecting Serotype in Human Sera.
    Röltgen K; Rose N; Ruggieri A; Warryn L; Scherr N; Pinho-Nascimento CA; Tamborrini M; Jaenisch T; Pluschke G
    J Immunol; 2018 Jun; 200(11):3857-3866. PubMed ID: 29661824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure.
    Desprès P; Frenkiel MP; Deubel V
    Virology; 1993 Sep; 196(1):209-19. PubMed ID: 8356794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.